author-photo

Antoni Picornell

Complutense University of Madrid

13

Papers

193

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

2019 BMC Genomics
Show All
- Source
- Cite
- Save
Citations (14)
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

2018 Blood Advances
Show All
- Source
- Cite
- Save
Citations (15)
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (36)
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (34)
162PDPathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4)

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial (Breast Cancer Research and Treatment, (2016), 156, 3, (507-515), 10.1007/s10549-016-3792-1)

2017 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (63)
408PValidation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol

2016 JMIR Research Protocols
Show All
- Source
- Cite
- Save
Citations (5)
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

2016 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (22)